Transient expression of thyrotropin releasing hormone peptide and mRNA in the rat hippocampus following global cerebral ischemia/reperfusion injury

References

• Boler J, Enzmann F, Folkers K, et al. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 1969;37(4):705–710.
   PubMed Web of Science ®Google Scholar
• Fekete C, Mihaly E, Luo LG, et al. Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic–pituitary–thyroid axis during fasting. J Neurosci. 2000;20(24):9224–9234.
   PubMed Web of Science ®Google Scholar
• Lechan RM, Wu P, Jackson IM. Immunocytochemical distribution in rat brain of putative peptides derived from thyrotropin-releasing hormone prohormone. Endocrinology. 1987;121(5):1879–1891.
   PubMed Web of Science ®Google Scholar
• Hokfelt T, Tsuruo Y, Ulfhake B, et al. Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. Ann N Y Acad Sci. 1989;553:76–105.
   PubMed Web of Science ®Google Scholar
• Sharif NA. Quantitative autoradiography of TRH receptors in discrete brain regions of different mammalian species. Ann N Y Acad Sci. 1989;553:147–175.
   PubMed Web of Science ®Google Scholar
• Heuer H, SchaFer MK, O'Donnell D, et al. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol. 2000;428(2):319–336.
   PubMed Web of Science ®Google Scholar
• Joseph-Bravo P, Uribe RM, Vargas MA, et al. Multifactorial modulation of TRH metabolism. Cell Mol Neurobiol. 1998;18(2):231–247.
   PubMed Web of Science ®Google Scholar
• Horita A. An update on the CNS actions of TRH and its analogs. Life Sci. 1998;62(17–18):1443–1448. 1998
   PubMed Web of Science ®Google Scholar
• Pizzi M, Boroni F, Benarese M, et al. Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. Eur J Pharmacol. 1999;370(2):133–137.
   PubMed Web of Science ®Google Scholar
• Prokai L. Central nervous system effects of thyrotropin-releasing hormone and its analogues: Opportunities and perspectives for drug discovery and development. Prog Drug Res. 2002;59:133–169.
   PubMedGoogle Scholar
• Gary KA, Sevarino KA, Yarbrough GG, et al. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: Implications for TRH-based therapeutics. J Pharmacol Exp Ther. 2003;305(2):410–416.
   PubMed Web of Science ®Google Scholar
• Deng PY, Porter JE, Shin HS, et al. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J Physiol. 2006;577(Pt 2):497–511.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Mariscal M, de Gortari P, Lopez-Rubalcava C, et al. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety. Psychoneuroendocrinology. 2008;33(2):198–213.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Mariscal M, Sanchez E, Rebolledo-Solleiro D, et al. The acute response of the amygdalar TRH system to psychogenic stressors varies dependent on the paradigm and circadian condition. Brain Res. 2012;1452:73–84.
   PubMed Web of Science ®Google Scholar
• Alexandrov AV. Current and future recanalization strategies for acute ischemic stroke. J Intern Med. 2010;267(2):209–219.
   PubMed Web of Science ®Google Scholar
• Amantea D, Nappi G, Bernardi G, et al. Post-ischemic brain damage: Pathophysiology and role of inflammatory mediators. FEBS J. 2009;276(1):13–26.
   PubMed Web of Science ®Google Scholar
• Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982;239(1):57–69.
   PubMed Web of Science ®Google Scholar
• Petito CK, Feldmann E, Pulsinelli WA, et al. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 1987;37(8):1281–1286.
   PubMed Web of Science ®Google Scholar
• Nitatori T, Sato N, Waguri S, et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci. 1995;15(2):1001–1011.
   PubMed Web of Science ®Google Scholar
• Shishido Y, Furushiro M, Tanabe S, et al. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats. Eur J Pharmacol. 1999;372(2):135–142. 14
   PubMed Web of Science ®Google Scholar
• Urayama A, Yamada S, Kimura R, et al. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice. Life Sci. 2002;72(4–5):601–607.
   PubMed Web of Science ®Google Scholar
• Rajput SK, Siddiqui MA, Kumar V, et al. Protective effects of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia. Peptides. 2011;32(6):1225–1231.
   PubMed Web of Science ®Google Scholar
• Pulsinelli WA, Buchan AM. The four-vessel occlusion rat model: Method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke. 1988;19(7):913–914.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002;958(2):439–447.
   PubMed Web of Science ®Google Scholar
• Yu Q, Guo Z, Liu X, et al. Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia. Purinergic Signal. 2013;9(4):663–675.
   PubMed Web of Science ®Google Scholar
• Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11(1):47–60.
   PubMed Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858.
   PubMed Web of Science ®Google Scholar
• Sui QQ, Zhu J, Li X, et al. A modified protocol for the detection of three different mRNAs with a new-generation in situ hybridization chain reaction on frozen sections. J Mol Histol. 2016;47(6):511–529.
   PubMed Web of Science ®Google Scholar
• Guo W, Xu X, Gao X, et al. Expression of P2X5 receptors in the mouse CNS. Neuroscience. 2008;156(3):673–692.
   PubMed Web of Science ®Google Scholar
• Nillni EA. Neuroregulation of ProTRH biosynthesis and processing. Endocrine. 1999;10(3):185–199.
   PubMed Web of Science ®Google Scholar
• Pu LP, Ma W, Barker JL, et al. Differential coexpression of genes encoding prothyrotropin-releasing hormone (pro-TRH) and prohormone convertases (PC1 and PC2) in rat brain neurons: Implications for differential processing of pro-TRH. Endocrinology. 1996;137(4):1233–1241.
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Stahl CE, Redei E, et al. Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats. Neuroreport. 1999;10(17):3501–3505.
   PubMed Web of Science ®Google Scholar
• Ploski JE, Newton SS, Duman RS. Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem. 2006;99(4):1122–1132.
   PubMed Web of Science ®Google Scholar
• Knoblach SM, Kubek MJ. Thyrotropin-releasing hormone release is enhanced in hippocampal slices after electroconvulsive shock. J Neurochem. 1994;62(1):119–125.
   PubMed Web of Science ®Google Scholar
• Knoblach SM, Kubek MJ. Increases in thyrotropin-releasing hormone messenger RNA expression induced by a model of human temporal lobe epilepsy: Effect of partial and complete kindling. Neuroscience. 1997;76(1):85–95.
   PubMed Web of Science ®Google Scholar
• Kubek MJ, Knoblach SM, Sharif NA, et al. Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol. 1993;33(1):70–76.
   PubMed Web of Science ®Google Scholar
• Ogawa N, Hirose Y, Mori A, et al. Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures. Regul Pept. 1985;12(3):249–256.
   PubMedGoogle Scholar
• Rosen JB, Cain CJ, Weiss SR, et al. Alterations in mRNA of enkephalin, dynorphin and thyrotropin releasing hormone during amygdala kindling: An in situ hybridization study. Brain Res Mol Brain Res. 1992;15(3–4):247–255.
   PubMedGoogle Scholar
• Rosen JB, Abramowitz J, Post RM. Colocalization of TRH mRNA and Fos-like immunoreactivity in limbic structures following amygdala kindling. Mol Cell Neurosci. 1993;4(4):335–342.
   PubMed Web of Science ®Google Scholar
• Rosen JB, Kim SY, Post RM. Differential regional and time course increases in thyrotropin-releasing hormone, neuropeptide Y and enkephalin mRNAs following an amygdala kindled seizure. Brain Res Mol Brain Res. 1994;27(1):71–80.
   PubMedGoogle Scholar
• Lee SL, Stewart K, Goodman RH. Structure of the gene encoding rat thyrotropin releasing hormone. J Biol Chem. 1988;263(32):16604–16609.
   PubMed Web of Science ®Google Scholar
• Kamme F, Campbell K, Wieloch T. Biphasic expression of the fos and jun families of transcription factors following transient forebrain ischaemia in the rat. Effect of hypothermia. Eur J Neurosci. 1995;7(10):2007–2016.
   PubMed Web of Science ®Google Scholar
• Keller HH, Bartholini G, Pletscher A. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature. 1974;248(448):528–529.
   PubMed Web of Science ®Google Scholar
• Faden AI. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol. 1996;78(1):12–17.
   PubMedGoogle Scholar
• Faden AI, Demediuk P, Panter SS, et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244(4906):798–800.
   PubMed Web of Science ®Google Scholar
• Zhang L, Rzigalinski BA, Ellis EF, et al. Reduction of voltage-dependent Mg2+ blockade of NMDA current in mechanically injured neurons. Science. 1996;274(5294):1921–1923.
   PubMed Web of Science ®Google Scholar
• Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol. 1998;54(4):369–415.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999;22(9):391–397.
   PubMed Web of Science ®Google Scholar
• Manaker S, Winokur A, Rostene WH, et al. Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J Neurosci. 1985;5(1):167–174.
   PubMed Web of Science ®Google Scholar
• Aragay AM, Katz A, Simon MI. The G alpha q and G alpha 11 proteins couple the thyrotropin-releasing hormone receptor to phospholipase C in GH3 rat pituitary cells. J Biol Chem. 1992;267(35):24983–24988.
   PubMed Web of Science ®Google Scholar
• Hsieh KP, Martin TF. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol. 1992;6(10):1673–1681.
   PubMedGoogle Scholar
• O'Dowd BF, Lee DK, Huang W, et al. TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol Endocrinol. 2000;14(1):183–193.
   PubMedGoogle Scholar
• Shuaib A, Ijaz S, Hemmings S, et al. Decreased glutamate release during hypothyroidism may contribute to protection in cerebral ischemia. Exp Neurol. 1994;128(2):260–265.
   PubMed Web of Science ®Google Scholar
• Alevizaki M, Synetou M, Xynos K, et al. Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol. 2006;65(3):369–372.
   PubMed Web of Science ®Google Scholar
• Rastogi L, Godbole MM, Ray M, et al. Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult. Exp Neurol. 2006;200(2):290–300.
   PubMed Web of Science ®Google Scholar
• Rastogi L, Gupta S, Godbole MM. Pathophysiological basis for thyrotoxicosis as an aggravating factor in post-ischemic brain injury in rats. J Endocrinol. 2008;196(2):335–341.
   PubMed Web of Science ®Google Scholar
• Rastogi L, Godbole MM, Sinha RA, et al. Reverse triiodothyronine (rT3) attenuates ischemia-reperfusion injury. Biochem Biophys Res Commun. 2018;506(3):597–603.
   PubMed Web of Science ®Google Scholar
• Akhoundi FH, Ghorbani A, Soltani A, et al. Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism. Neurology. 2011;77(4):349–354. 26
   PubMed Web of Science ®Google Scholar
• Wollenweber FA, Zietemann V, Gschwendtner A, et al. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke. 2013;44(5):1446–1448.
   PubMed Web of Science ®Google Scholar
• Jiang X, Xing H, Wu J, et al. Prognostic value of thyroid hormones in acute ischemic stroke - a meta analysis. Sci Rep. 2017;7(1):1625624
   PubMedGoogle Scholar
• Vorhees CV, Williams MT. Assessing spatial learning and memory in rodents. Ilar J. 2014;55(2):310–332.
   PubMed Web of Science ®Google Scholar